All News #Library
Others
SyneuRx reveals results of COVID-19 candidate trial
08 Aug 2022 //
PHARMATIMES
SyneuRx Announces Final Results of PII Trial of Pentarlandir (SNB01)
31 Jul 2022 //
BUSINESSWIRE

Market Place
Sourcing Support